Contact
searchSearch
HMP Global

Volume 26 - Issue 12 - December, 2014

Feature

Review
Saphenous Vein Graft Intervention: Status Report 2014
11/26/2014
Jonathan Soverow, MD, MPH; Michael S. Lee, MD, DPM, FACFAS, FACC, FSCAI
This paper reviews the most recent data and techniques available to the interventionalist seeking to improve outcomes after SVG intervention.
This paper reviews the most recent data and techniques available to the interventionalist seeking to improve outcomes after SVG intervention.
This paper reviews the most...
11/26/2014
Journal of Invasive Cardiology
Original Contribution
Risk of Developing Coronary Artery Disease Following a Normal Coronary Angiogram in Middle-Aged Adults
11/26/2014
George A. Stouffer, MD; Maheswara S. G. Rao Golla, MBBS; Siddhartha Rao, MD, RPVI; Chris Wiesen, PhD; Michael Yeung, MD; Timir K. Paul, MD, PhD, MPH, FACC, FSCAI, FAHA
It is unknown whether coronary angiography in middle-aged adults showing no evidence of atherosclerosis identifies individuals at low risk for subsequent development of coronary artery disease (CAD). Even mild atherosclerosis increased the...
It is unknown whether coronary angiography in middle-aged adults showing no evidence of atherosclerosis identifies individuals at low risk for subsequent development of coronary artery disease (CAD). Even mild atherosclerosis increased the...
It is unknown whether coronary...
11/26/2014
Journal of Invasive Cardiology
Plaque Composition and Dynamics
Determinants of Neointimal Proliferation and Stent Coverage After Intracoronary Therapy With Drug-Eluting Devices in Stable Coronary Artery Disease: Role of Endothelial Progenitor Cells and Interleukin-1 Family Cytokines
11/26/2014
Hans-Rainer Figulla, MD; Sylvia Otto, MD; Kristina Nitsche; Johannes Gassdorf; Florian Janiak; Björn Goebel, MD; Tudor C. Poerner, MD; Christian Jung, MD, PhD
We used OCT to assess the influence of circulating endothelial progenitor cells and levels of Il-1 cytokines on stent coverage and in-stent proliferation. A high EPC count seems to be a favorable individual patient factor, since it was...
We used OCT to assess the influence of circulating endothelial progenitor cells and levels of Il-1 cytokines on stent coverage and in-stent proliferation. A high EPC count seems to be a favorable individual patient factor, since it was...
We used OCT to assess the...
11/26/2014
Journal of Invasive Cardiology
Original Contribution
Comparison of Provisional 1-Stent and 2-Stent Strategies in Diabetic Patients With True Bifurcation Lesions: The EES Bifurcation Study
11/26/2014
Jason C. Kovacic, MD, PhD; George D. Dangas, MD, PhD; Pedro R. Moreno, MD; Omar A. Meelu, MS; Matthew I. Tomey, MD; Samantha Sartori, PhD; Nisharahmed Kherada, MD; Prakash Krishnan, MD, FACC; Robert T. Pyo, MD; Roxana Mehran, MD; Kleanthis N. Theodoropoulos, MD; Marco G. Mennuni, MD; Annapoorna S. Kini, MD, MRCP, FACC; Swapna Sayeneni, MBBS; Usman Baber, MD; Samin K. Sharma, MD, FACC, FSCAI
Diabetes mellitus is associated with greater atherosclerotic burden and higher incidence of bifurcation lesions, and unfavorable outcomes after PCI. In this series of diabetic patients undergoing complex bifurcation PCI using...
Diabetes mellitus is associated with greater atherosclerotic burden and higher incidence of bifurcation lesions, and unfavorable outcomes after PCI. In this series of diabetic patients undergoing complex bifurcation PCI using...
Diabetes mellitus is associated...
11/26/2014
Journal of Invasive Cardiology
Original Contribution
Three-Year Outcomes of Percutaneous Coronary Intervention With Next-Generation Zotarolimus-Eluting Stents for De Novo Coronary Bifurcation Lesions
11/26/2014
Franz-Josef Neumann, MD; Ran Kornowski, MD; Miroslaw Ferenc, MD; Stephan Windecker, MD; Sigmund Silber, MD; Jorge A. Belardi, MD, PhD; Petr Widimsky, MD; Patrick W. Serruys, MD, PhD
We investigate the outcomes of percutaneous coronary intervention (PCI) in bifurcation versus non-bifurcation lesions using the next-generation Resolute zotarolimus-eluting stent. There was an increased risk associated with bifurcation...
We investigate the outcomes of percutaneous coronary intervention (PCI) in bifurcation versus non-bifurcation lesions using the next-generation Resolute zotarolimus-eluting stent. There was an increased risk associated with bifurcation...
We investigate the outcomes of...
11/26/2014
Journal of Invasive Cardiology
Clinical Images
CLINICAL IMAGES / Bioresorbable Stent Restenosis: New Devices, Novel Situations
11/26/2014
Antonio Fernandez-Ortiz, MD, PhD; Ivan Nunez-Gil, MD; Corina Biagioni, MD; Mauro Echavarría-Pinto, MD; Gisela Feltes, MD; Javier Escaned, MD, PhD
We describe one of the first cases of bioresorbable vascular scaffold restenosis. We treated it like a drug-eluting stent restenosis, performing first an intracoronary optical coherence tomography scan in order to identify the left descending...
We describe one of the first cases of bioresorbable vascular scaffold restenosis. We treated it like a drug-eluting stent restenosis, performing first an intracoronary optical coherence tomography scan in order to identify the left descending...
We describe one of the first...
11/26/2014
Journal of Invasive Cardiology
Correction of Acquired von Willebrand Syndrome by Transcatheter Aortic Valve Implantation
11/26/2014
Hendrik Treede, MD; Patrick Diemert, MD; Stefan Blankenberg, MD; Olivier Marggraf, MD; Moritz Seiffert, MD; Sonja Schneppenheim, MD; Hermann Reichenspurner, MD; Anne Daubmann; Ulrich Budde, MD
Transcatheter aortic valve implantation (TAVI) is gaining importance, but the influence of this new technique on acquired von Willebrand syndrome has never been examined. We conclude that acquired von Willebrand syndrome due to aortic valve...
Transcatheter aortic valve implantation (TAVI) is gaining importance, but the influence of this new technique on acquired von Willebrand syndrome has never been examined. We conclude that acquired von Willebrand syndrome due to aortic valve...
Transcatheter aortic valve...
11/26/2014
Journal of Invasive Cardiology
Bioresorbable Vascular Scaffold Subacute Thrombosis and the Kounis Syndrome
11/26/2014
Grigorios Tsigkas, MD, PhD; Nicholas G. Kounis, MD, PhD, FESC, FACC; George N. Kounis, MSc, MD; George D. Soufras, MD, PhD
A thoughtful commentary on a July 2014 JIC case report by Ruiz-Salmerón, et al, who provide a rebuttal to this letter.
A thoughtful commentary on a July 2014 JIC case report by Ruiz-Salmerón, et al, who provide a rebuttal to this letter.
A thoughtful commentary on a...
11/26/2014
Journal of Invasive Cardiology
Outpatient Percutaneous Coronary Intervention: Has Its Time Come?
11/26/2014
Rami N. Khouzam, MD, FACC, FACP, FSCAI; Srihari S. Naidu, MD; Mohamad Khaled Soufi, MD; Ramy Nakhla, MD
Abstract: In the context of the rising health-care costs in the United States and the fact that approximately 1 million percutaneous coronary intervention (PCI) procedures are performed in the United States annually with a cost approaching...
Abstract: In the context of the rising health-care costs in the United States and the fact that approximately 1 million percutaneous coronary intervention (PCI) procedures are performed in the United States annually with a cost approaching...
Abstract: In the context of the...
11/26/2014
Journal of Invasive Cardiology

Insights

Commentary
Treatment of Coronary Bifurcations: Progress and Future
11/26/2014
Ganesh Athappan, MD; Samin K. Sharma, MD, FACC, FSCAI
The authors provide their thoughts on the current state of bifurcation interventions. Despite the advances in stent technology and catheter techniques, bifurcation lesions present a formidable challenge to the interventional cardiologist...
The authors provide their thoughts on the current state of bifurcation interventions. Despite the advances in stent technology and catheter techniques, bifurcation lesions present a formidable challenge to the interventional cardiologist...
The authors provide their...
11/26/2014
Journal of Invasive Cardiology

News

Mitral Valve Intervention
Edwards SAPIEN M3 Receives CE Mark, Becoming World’s First Transfemoral Transcatheter Mitral Valve Replacement System
04/14/2025
The SAPIEN M3 mitral valve replacement system received CE Mark for the transcatheter treatment of patients with symptomatic (moderate-to-severe or severe) mitral regurgitation (MR) who are deemed unsuitable for surgery or transcatheter...
The SAPIEN M3 mitral valve replacement system received CE Mark for the transcatheter treatment of patients with symptomatic (moderate-to-severe or severe) mitral regurgitation (MR) who are deemed unsuitable for surgery or transcatheter...
The SAPIEN M3 mitral valve...
04/14/2025
Cath Lab Digest
quantitative flow ratio
Medis QFR 3.0 Launches in the U.S.
04/07/2025
Medis QFR® is a safe(1) and wire-free software solution that assesses angiography-derived coronary physiology in patients with ischemic CAD. Medis QFR® is a wire-free technique that estimates FFR values using computational fluid dynamics...
Medis QFR® is a safe(1) and wire-free software solution that assesses angiography-derived coronary physiology in patients with ischemic CAD. Medis QFR® is a wire-free technique that estimates FFR values using computational fluid dynamics...
Medis QFR® is a safe(1) and...
04/07/2025
Cath Lab Digest
Intravascular Lithotripsy
Shockwave Medical Enrolls First Patient in FORWARD CAD Pivotal Study of Novel Forward Intravascular Lithotripsy Platform
04/07/2025
Investigators in the study will assess the safety and effectiveness of the Shockwave Javelin Coronary IVL Catheter for the treatment of calcified, difficult-to-cross stenotic de novo coronary artery lesions prior to stenting.
Investigators in the study will assess the safety and effectiveness of the Shockwave Javelin Coronary IVL Catheter for the treatment of calcified, difficult-to-cross stenotic de novo coronary artery lesions prior to stenting.
Investigators in the study will...
04/07/2025
Cath Lab Digest
thrombectomy
Seven New Data Sets Demonstrate Penumbra’s Computer Assisted Vacuum Thrombectomy (CAVT) Technology Is Safe, Fast and Effective, Improves Patient Outcomes, and Delivers Healthcare Resource Benefits
04/07/2025
Penumbra, Inc, announced seven significant computer assisted vacuum thrombectomy (CAVT™) data presentations during the 2025 Society of Interventional Radiology (SIR) Annual Scientific Meeting. The data showed that CAVT as a frontline therapy...
Penumbra, Inc, announced seven significant computer assisted vacuum thrombectomy (CAVT™) data presentations during the 2025 Society of Interventional Radiology (SIR) Annual Scientific Meeting. The data showed that CAVT as a frontline therapy...
Penumbra, Inc, announced seven...
04/07/2025
Cath Lab Digest
Intravascular Imaging
ECLIPSE Trial: Intravascular Imaging Can Improve Outcomes for Complex Stenting Procedures in Patients with High-Risk Calcified CAD
03/31/2025
“The ECLIPSE trial shows that use of intravascular imaging (IVI) to guide coronary stenting in severely calcified lesions prevents death, stent thrombosis, and unplanned repeat procedures in this high-risk patient population,” says first...
“The ECLIPSE trial shows that use of intravascular imaging (IVI) to guide coronary stenting in severely calcified lesions prevents death, stent thrombosis, and unplanned repeat procedures in this high-risk patient population,” says first...
“The ECLIPSE trial shows that...
03/31/2025
Cath Lab Digest
Aortic Stenosis
New Data Confirm Rapid, Unpredictable Progression of Severe Aortic Stenosis and Need for Urgent Referral and Evaluation of Patients
03/31/2025
New data from DETECT AS and the EARLY TAVR Trial were presented at ACC.25 in Chicago, addressing the critical needs of patients with structural heart disease.
New data from DETECT AS and the EARLY TAVR Trial were presented at ACC.25 in Chicago, addressing the critical needs of patients with structural heart disease.
New data from DETECT AS and the...
03/31/2025
Cath Lab Digest
CAD in Women
New Intermountain Health Study Finds Gap Between Heart Disease Outcomes in Men and Women Has Narrowed Over Past 20 Years  
03/31/2025
Women studied tended to be older with more comorbidities (like high blood pressure, diabetes, and history of stroke and heart failure), have more stable chest pain, and experience less severe chest pain or heart attack when they came into the...
Women studied tended to be older with more comorbidities (like high blood pressure, diabetes, and history of stroke and heart failure), have more stable chest pain, and experience less severe chest pain or heart attack when they came into the...
Women studied tended to be older...
03/31/2025
Cath Lab Digest
AI
HeartFocus Clinical Trial Proves AI Can Empower Novices to Deliver Diagnostic-Quality Cardiac Ultrasounds
03/31/2025
Results showed that 100% of exams conducted by novices using HeartFocus met the diagnostic standards for all primary endpoints, with a strong correlation to expert-acquired scans across qualitative and quantitative assessments.
Results showed that 100% of exams conducted by novices using HeartFocus met the diagnostic standards for all primary endpoints, with a strong correlation to expert-acquired scans across qualitative and quantitative assessments.
Results showed that 100% of...
03/31/2025
Cath Lab Digest
plaque analysis
CONFIRM2 Registry: Late-Breaking Clinical Trial Results Demonstrate the Predictive Power of Cleerly's AI-QCT for Women’s Cardiovascular Risk at ACC.25
03/31/2025
The findings demonstrate that AI-QCT features of coronary artery disease (CAD), as detected by Cleerly’s AI-QCT, can identify women at high risk for major adverse cardiovascular events (MACE) and improves risk stratification - a population...
The findings demonstrate that AI-QCT features of coronary artery disease (CAD), as detected by Cleerly’s AI-QCT, can identify women at high risk for major adverse cardiovascular events (MACE) and improves risk stratification - a population...
The findings demonstrate that...
03/31/2025
Cath Lab Digest
Statins
CorCal Outcomes Study: Who Needs a Statin? Intermountain Study Compares Prescribing Recommendations Based on Traditional Risk Factors vs. Coronary Artery Calcium Scoring
03/31/2025
The research is part of CorCal Outcomes, a large, randomized clinical trial at Intermountain Health that is comparing the PCE versus CAC score guidance to initiate a statin prescription for patients for primary prevention of coronary heart...
The research is part of CorCal Outcomes, a large, randomized clinical trial at Intermountain Health that is comparing the PCE versus CAC score guidance to initiate a statin prescription for patients for primary prevention of coronary heart...
The research is part of CorCal...
03/31/2025
Cath Lab Digest

Mitral Valve Intervention
Edwards SAPIEN M3 Receives CE Mark, Becoming World’s First Transfemoral Transcatheter Mitral Valve Replacement System
04/14/2025
The SAPIEN M3 mitral valve replacement system received CE Mark for the transcatheter treatment of patients with symptomatic (moderate-to-severe or severe) mitral regurgitation (MR) who are deemed unsuitable for surgery or transcatheter...
The SAPIEN M3 mitral valve replacement system received CE Mark for the transcatheter treatment of patients with symptomatic (moderate-to-severe or severe) mitral regurgitation (MR) who are deemed unsuitable for surgery or transcatheter...
The SAPIEN M3 mitral valve...
04/14/2025
Cath Lab Digest
Murai Figure
Clinical Videos
Intravascular Lithotripsy for In-Stent Calcified Neoatherosclerosis
04/09/2025
Video Supplement to "Intravascular Lithotripsy for In-Stent Calcified Neoatherosclerosis" (Clinical Image).
Video Supplement to "Intravascular Lithotripsy for In-Stent Calcified Neoatherosclerosis" (Clinical Image).
Video Supplement to...
04/09/2025
Journal of Invasive Cardiology
Clinical Images
Intravascular Lithotripsy for In-Stent Calcified Neoatherosclerosis
04/09/2025
Keima Wayama, MD; Kota Murai, MD, PhD; Teruo Noguchi, MD, PhD
An 80-year-old man with a history of acute inferior myocardial infarction was admitted to our hospital. He had undergone bare-metal stent (3.5/28 mm) implantation in the mid-right coronary artery 22 years prior.
An 80-year-old man with a history of acute inferior myocardial infarction was admitted to our hospital. He had undergone bare-metal stent (3.5/28 mm) implantation in the mid-right coronary artery 22 years prior.
An 80-year-old man with a...
04/09/2025
Journal of Invasive Cardiology
quantitative flow ratio
Medis QFR 3.0 Launches in the U.S.
04/07/2025
Medis QFR® is a safe(1) and wire-free software solution that assesses angiography-derived coronary physiology in patients with ischemic CAD. Medis QFR® is a wire-free technique that estimates FFR values using computational fluid dynamics...
Medis QFR® is a safe(1) and wire-free software solution that assesses angiography-derived coronary physiology in patients with ischemic CAD. Medis QFR® is a wire-free technique that estimates FFR values using computational fluid dynamics...
Medis QFR® is a safe(1) and...
04/07/2025
Cath Lab Digest
Agstam Figure
Clinical Videos
Tenecteplase-Assisted Transapical Drainage of Tuberculous Pyopericardium
04/07/2025
Video Supplement to "Tenecteplase-Assisted Transapical Drainage of Tuberculous Pyopericardium" (Clinical Image).
Video Supplement to "Tenecteplase-Assisted Transapical Drainage of Tuberculous Pyopericardium" (Clinical Image).
Video Supplement to...
04/07/2025
Journal of Invasive Cardiology
Clinical Images
Tenecteplase-Assisted Transapical Drainage of Tuberculous Pyopericardium
04/07/2025
Venkatakrishnan Ramakumar, MD, DM; Durlabhesh Rawat, MD, DM; Sourabh Agstam, MD, DM
A 35-year-old man with human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) and a CD4 count of 61 cells per mm3 (normal range: 500-1200 cells/mm3) presented with worsening shortness of breath and orthopnoea over the...
A 35-year-old man with human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) and a CD4 count of 61 cells per mm3 (normal range: 500-1200 cells/mm3) presented with worsening shortness of breath and orthopnoea over the...
A 35-year-old man with human...
04/07/2025
Journal of Invasive Cardiology
Intravascular Lithotripsy
Shockwave Medical Enrolls First Patient in FORWARD CAD Pivotal Study of Novel Forward Intravascular Lithotripsy Platform
04/07/2025
Investigators in the study will assess the safety and effectiveness of the Shockwave Javelin Coronary IVL Catheter for the treatment of calcified, difficult-to-cross stenotic de novo coronary artery lesions prior to stenting.
Investigators in the study will assess the safety and effectiveness of the Shockwave Javelin Coronary IVL Catheter for the treatment of calcified, difficult-to-cross stenotic de novo coronary artery lesions prior to stenting.
Investigators in the study will...
04/07/2025
Cath Lab Digest
thrombectomy
Seven New Data Sets Demonstrate Penumbra’s Computer Assisted Vacuum Thrombectomy (CAVT) Technology Is Safe, Fast and Effective, Improves Patient Outcomes, and Delivers Healthcare Resource Benefits
04/07/2025
Penumbra, Inc, announced seven significant computer assisted vacuum thrombectomy (CAVT™) data presentations during the 2025 Society of Interventional Radiology (SIR) Annual Scientific Meeting. The data showed that CAVT as a frontline therapy...
Penumbra, Inc, announced seven significant computer assisted vacuum thrombectomy (CAVT™) data presentations during the 2025 Society of Interventional Radiology (SIR) Annual Scientific Meeting. The data showed that CAVT as a frontline therapy...
Penumbra, Inc, announced seven...
04/07/2025
Cath Lab Digest
Original Contribution
Rotational Atherectomy for Calcified Coronary Lesions in Severe Aortic Stenosis Before Transcatheter Aortic Valve Implantation
04/04/2025
Sultan Alotaibi, MD, MSc; Abdelhakim Allali, MD; Hajo Heyer, MD; Nader Mankerious, MD; Martin Landt, MD; Mohamed Abdel-Wahab, MD; Volker Geist, MD; Ralph Tölg, MD; Mohamed Samy, MD; Gert Richardt, MD; Karim Elbasha, MD
The authors aimed to compare in-hospital outcomes following rotational atherectomy in patients with severe aortic stenosis (AS) before transcatheter aortic valve implantation vs patients without AS.
The authors aimed to compare in-hospital outcomes following rotational atherectomy in patients with severe aortic stenosis (AS) before transcatheter aortic valve implantation vs patients without AS.
The authors aimed to compare...
04/04/2025
Journal of Invasive Cardiology
Original Contribution
Can IodixAnol ReducE the Incidence of Adverse Renal or Cardiac Events in Chronic Total Occlusion Interventions (CARE-CTO): A Substudy of the PROGRESS-CTO Registry
04/02/2025
Dimitrios Strepkos, MD; Athanasios Rempakos, MD; Michaella Alexandrou, MD; Deniz Mutlu, MD; Pedro E.P. Carvalho, MD; Ozgur Selim Ser, MD; Khaldoon Alaswad, MD; Mir Babar Basir, DO; Dmitrii Khelimskii, MD; Oleg Krestyaninov, MD; Jaikirshan J. Khatri, MD; Laura D. Young, MD; Omer Goktekin, MD; Paul Poommipanit, MD; Farouc A. Jaffer, MD, PhD; Sevket Gorgulu, MD; Ahmed M. ElGuindy, MD; Nidal Abi Rafeh, MD; Olga C. Mastrodemos, BA; Bavana V. Rangan, BDS, MPH; Sandeep Jalli, DO; Konstantinos Voudris, MD, PhD; Yader Sandoval, MD; M. Nicholas Burke, MD; Emmanouil S. Brilakis, MD, PhD
The impact of contrast type in chronic total occlusion (CTO) percutaneous coronary intervention (PCI) remains controversial. The authors sought to evaluate the impact of contrast medium selection on patients undergoing CTO PCI.
The impact of contrast type in chronic total occlusion (CTO) percutaneous coronary intervention (PCI) remains controversial. The authors sought to evaluate the impact of contrast medium selection on patients undergoing CTO PCI.
The impact of contrast type in...
04/02/2025
Journal of Invasive Cardiology

December 2014 Volume 26 Issue 12

View Issue Archive
Editorial Correspondence

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use